Pilot trial of selecting molecularly guided therapy for patients with non-V600 BRAF-mutant metastatic melanoma: Experience of the SU2C/MRA melanoma dream team.
Molecular Cancer Therapeutics.
Times cited: 16
Toward precision medicine in glioblastoma: The promise and the challenges.
Times cited: 97
Molecular cytogenetic analysis of i(12p)‐negative human male germ cell tumors.
Genes Chromosomes and Cancer.
Times cited: 122